SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-3.1
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex3-1.htm

Chunk 10 of 11
Word Count: 1011
Character Count: 6553

Document Content:

fullest extent permitted by applicable law, the Corporation is authorized to provide indemnification of (and advancement of expenses to) directors, officers and agents of the Corporation (and any other persons to which General Corporation Law permits the Corporation to provide indemnification) through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section 145 of the General Corporation Law. Any amendment, repeal or modification of the foregoing provisions of this Article Tenth shall not (a) adversely affect any right or protection of any director, officer or other agent of the Corporation existing at the time of such amendment, repeal or modification or (b) increase the liability of any director of the Corporation with respect to any acts or omissions of such director, officer or agent occurring prior to, such amendment, repeal or modification.

Eleventh:
The Corporation renounces, to the fullest extent permitted by law, any interest or expectancy of the Corporation in, or in being offered
an opportunity to participate in, any Excluded Opportunity. An “Excluded Opportunity” is any matter, transaction or
interest that is presented to, or acquired, created or developed by, or which otherwise comes into the possession of (i) any director
of the Corporation who is not an employee of the Corporation or any of its subsidiaries, or (ii) any holder of Preferred Stock or any
partner, member, director, stockholder, employee, affiliate or agent of any such holder, other than someone who is an employee of the
Corporation or any of its subsidiaries (collectively, the persons referred to in clauses (i) and (ii) are “Covered
Persons”), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise
comes into the possession of, a Covered Person expressly and solely in such Covered Person’s capacity as a director of the Corporation
while such Covered Person is performing services in such capacity. Any repeal or modification of this Article Eleventh will only be prospective
and will not affect the rights under this Article Eleventh in effect at the time of the occurrence of any actions or omissions to act
giving rise to liability. Notwithstanding anything to the contrary contained elsewhere in this Third Amended and Restated Certificate
of Incorporation, the affirmative vote of the holders of at least 60% of the shares of Preferred Stock then outstanding, will be required
to amend or repeal, or to adopt any provisions inconsistent with this Article Eleventh.

Twelfth:
Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall
be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought
on behalf of the Corporation, (ii) any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee
of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation,
its directors, officers or employees arising pursuant to any provision of the Delaware General Corporation Law or the Corporation’s
certificate of incorporation or bylaws or (iv) any action asserting a claim against the Corporation, its directors, officers or employees
governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery
determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party
does not consent to the personal jurisdiction of the Court of Chancery within ten (10) days following such determination), which is vested
in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have
subject matter jurisdiction. If any provision or provisions of this Article Twelfth shall be held to be invalid, illegal or unenforceable
as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity,
legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article Twelfth (including,
without limitation, each portion of any sentence of this Article Twelfth containing any such provision held to be invalid, illegal or
unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons
or entities and circumstances shall not in any way be affected or impaired thereby.

Thirteenth:
For purposes of Section 500 of the California Corporations Code (to the extent applicable), in connection with any repurchase of shares
of Common Stock permitted under this Third Amended and Restated Certificate of Incorporation from employees, officers, directors or consultants
of the Corporation in connection with a termination of employment or services pursuant to agreements or arrangements approved by the
Board of Directors (in addition to any other consent required under this Third Amended and Restated Certificate of Incorporation), such
repurchase may be made without regard to any “preferential dividends arrears amount” or “preferential rights amount”
(as those terms are defined in Section 500 of the California Corporations Code). Accordingly, for purposes of making any calculation
under California Corporations Code Section 500 in connection with such repurchase, the amount of any “preferential dividends arrears
amount” or “preferential rights amount” (as those terms are defined therein) shall be deemed to be zero (0).

That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this corporation in
accordance with Section 228 of the General Corporation Law.

That this Certificate of Incorporation, which restates and integrates and further amends the provisions of this Corporation’s
Certificate of Incorporation, has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law.

[Signature
Page Follows]

WITNESS WHEREOF, this Third Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of this
corporation on this 29th day of March, 2023.

James
Dillon, President